IBDEI39X ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52250,1,3,0)
 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,52250,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,52250,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,52251,0)
 ;;=E10.44^^193^2526^1
 ;;^UTILITY(U,$J,358.3,52251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52251,1,3,0)
 ;;=3^DM Type 1 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,52251,1,4,0)
 ;;=4^E10.44
 ;;^UTILITY(U,$J,358.3,52251,2)
 ;;=^5002608
 ;;^UTILITY(U,$J,358.3,52252,0)
 ;;=E10.49^^193^2526^25
 ;;^UTILITY(U,$J,358.3,52252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52252,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,52252,1,4,0)
 ;;=4^E10.49
 ;;^UTILITY(U,$J,358.3,52252,2)
 ;;=^5002609
 ;;^UTILITY(U,$J,358.3,52253,0)
 ;;=E10.59^^193^2526^22
 ;;^UTILITY(U,$J,358.3,52253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52253,1,3,0)
 ;;=3^DM Type 1 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,52253,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,52253,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,52254,0)
 ;;=E10.610^^193^2526^9
 ;;^UTILITY(U,$J,358.3,52254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52254,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,52254,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,52254,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,52255,0)
 ;;=E10.618^^193^2526^23
 ;;^UTILITY(U,$J,358.3,52255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52255,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,52255,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,52255,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,52256,0)
 ;;=E10.630^^193^2526^30
 ;;^UTILITY(U,$J,358.3,52256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52256,1,3,0)
 ;;=3^DM Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,52256,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,52256,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,52257,0)
 ;;=E10.638^^193^2526^27
 ;;^UTILITY(U,$J,358.3,52257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52257,1,3,0)
 ;;=3^DM Type 1 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,52257,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,52257,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,52258,0)
 ;;=E10.641^^193^2526^15
 ;;^UTILITY(U,$J,358.3,52258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52258,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,52258,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,52258,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,52259,0)
 ;;=E10.649^^193^2526^16
 ;;^UTILITY(U,$J,358.3,52259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52259,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,52259,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,52259,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,52260,0)
 ;;=E10.65^^193^2526^14
 ;;^UTILITY(U,$J,358.3,52260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52260,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,52260,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,52260,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,52261,0)
 ;;=E10.69^^193^2526^29
 ;;^UTILITY(U,$J,358.3,52261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52261,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,52261,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,52261,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,52262,0)
 ;;=E10.8^^193^2526^33
 ;;^UTILITY(U,$J,358.3,52262,1,0)
 ;;=^358.31IA^4^2
